Detalhe da pesquisa
1.
Hepatocytes coordinate immune evasion in cancer via release of serum amyloid A proteins.
Nat Immunol
; 25(5): 755-763, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38641718
2.
Metabolic rewiring of macrophages by CpG potentiates clearance of cancer cells and overcomes tumor-expressed CD47-mediated 'don't-eat-me' signal.
Nat Immunol
; 20(3): 265-275, 2019 01 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-30664738
3.
The biological underpinnings of therapeutic resistance in pancreatic cancer.
Genes Dev
; 35(13-14): 940-962, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34117095
4.
EMT and dissemination precede pancreatic tumor formation.
Cell
; 148(1-2): 349-61, 2012 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-22265420
5.
Intratumoral Cell Neighborhoods Coordinate Outcomes in Pancreatic Ductal Adenocarcinoma.
Gastroenterology
; 166(6): 1114-1129, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38244727
6.
Hepatocytes direct the formation of a pro-metastatic niche in the liver.
Nature
; 567(7747): 249-252, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30842658
7.
Epacadostat Plus Pembrolizumab and Chemotherapy for Advanced Solid Tumors: Results from the Phase I/II ECHO-207/KEYNOTE-723 Study.
Oncologist
; 27(11): 905-e848, 2022 11 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36156099
8.
Overcoming immunotherapeutic resistance by targeting the cancer inflammation cycle.
Semin Cancer Biol
; 65: 38-50, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31954172
9.
Dual Targeting of Mesothelin and CD19 with Chimeric Antigen Receptor-Modified T Cells in Patients with Metastatic Pancreatic Cancer.
Mol Ther
; 28(11): 2367-2378, 2020 11 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32730744
10.
Platinum response characteristics of patients with pancreatic ductal adenocarcinoma and a germline BRCA1, BRCA2 or PALB2 mutation.
Br J Cancer
; 122(3): 333-339, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31787751
11.
Broadening the Impact of Immunotherapy to Pancreatic Cancer: Challenges and Opportunities.
Gastroenterology
; 156(7): 2056-2072, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30660727
12.
Phase I Study of Lentiviral-Transduced Chimeric Antigen Receptor-Modified T Cells Recognizing Mesothelin in Advanced Solid Cancers.
Mol Ther
; 27(11): 1919-1929, 2019 11 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31420241
13.
A Phase Ib/II Study of the JAK1 Inhibitor, Itacitinib, plus nab-Paclitaxel and Gemcitabine in Advanced Solid Tumors.
Oncologist
; 24(1): 14-e10, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30115734
14.
Activity of Mesothelin-Specific Chimeric Antigen Receptor T Cells Against Pancreatic Carcinoma Metastases in a Phase 1 Trial.
Gastroenterology
; 155(1): 29-32, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29567081
15.
Myeloid cells are required for PD-1/PD-L1 checkpoint activation and the establishment of an immunosuppressive environment in pancreatic cancer.
Gut
; 66(1): 124-136, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27402485
16.
CTLA-4/CD80 pathway regulates T cell infiltration into pancreatic cancer.
Cancer Immunol Immunother
; 66(12): 1609-1617, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28856392
17.
Exclusion of T Cells From Pancreatic Carcinomas in Mice Is Regulated by Ly6C(low) F4/80(+) Extratumoral Macrophages.
Gastroenterology
; 149(1): 201-10, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25888329
18.
Multiplexed Imaging Mass Cytometry Analysis Characterizes the Vascular Niche in Pancreatic Cancer.
Cancer Res
; 2024 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38695869
19.
Multimodal immune phenotyping reveals microbial-T cell interactions that shape pancreatic cancer.
Cell Rep Med
; 5(2): 101397, 2024 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38307029
20.
Repeated peripheral infusions of anti-EGFRvIII CAR T cells in combination with pembrolizumab show no efficacy in glioblastoma: a phase 1 trial.
Nat Cancer
; 5(3): 517-531, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38216766